Physical interaction of tumour suppressor p53/p73 with CCAAT-binding transcription factor 2 (CTF2) and differential regulation of human high-mobility group 1 (HMG1) gene expression
- 15 April 2003
- journal article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 371 (2) , 301-310
- https://doi.org/10.1042/bj20021646
Abstract
The CCAAT-binding transcription factor (CTF)/nuclear factor I (NF-I) group of cellular DNA-binding proteins recognizes the sequence GCCAAT and is implicated in eukaryotic transcription, as well as DNA replication. Molecular analysis of human CTF/NF-I cDNA clones revealed multiple mRNA species that contain alternative coding regions, apparently as a result of differential splicing. Expression and functional analysis established that individual gene products can bind to GCCAAT recognition sites and serve as both promoter-selective transcriptional activators and initiation factors for DNA replication. The interaction between CTF2 and p53/p73 was shown to modulate their ability to regulate transcription of their respective target genes. In the present paper, we report that p53 down-regulates the activity of the high mobility group 1 (HMG1) gene promoter, whereas p73α up-regulates the activity of this promoter. Furthermore, CTF2 transactivates p53-induced p21 promoter activity, but inhibits p73α-induced p21 promoter activity. Using deletion mutants, we found that the DNA-binding domains of both p53 and p73α are required for physical interaction with CTF2 via the regions between amino acid residues 161 and 223, and 228 and 312 respectively. CTF2 enhances the DNA-binding activity of p53 and inhibits the DNA-binding activity of p73α. These results provide novel information on the functional interplay between CTF2 and p53/p73 as important determinants of their function in cell proliferation, apoptosis, DNA repair and cisplatin resistance.Keywords
This publication has 48 references indexed in Scilit:
- Direct interaction of p53 with the Y-box binding protein, YB-1: a mechanism for regulation of human gene expressionOncogene, 2000
- Structure and function in the p53 familyCell Death & Differentiation, 1999
- Disruption of p53 in human cancer cells alters the responses to therapeutic agentsJournal of Clinical Investigation, 1999
- Excision of mismatched nucleotides from DNA: a potential mechanism for enhancing DNA replication fidelity by the wild-type p53 proteinOncogene, 1998
- p53 in growth control and neoplasiaBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1996
- p53 Status and the Efficacy of Cancer Therapy in VivoScience, 1994
- Transcription factor nuclear factor I proteins form stable homo‐ and heterodimersFEBS Letters, 1994
- The Genes for Transcription Factor Nuclear Factor I Give Rise to Corresponding Splice Variants between Vertebrate SpeciesJournal of Molecular Biology, 1994
- High mobility group proteins 1 and 2 function as general class II transcription factorsBiochemistry, 1990
- Structure and function of the adenovirus origin of replicationCell, 1984